Antares Pharma, Inc. (ATRS) New Drug Application Delayed Over Side Effects According to the consolidated amended complaint filed against the company’s officers and directors for alleged violations of the Securities

National Beverage Corp (FIZZ) Accused of Making Misleading Statements According to the complaint against the company’s officers and directors for breaches of fiduciary duties from July 17, 2014 through the

Align Technology, Inc. (ALGN) Accused of Failing to Disclose Negative Impact of its Invisalign Promotions According to the complaint against the company’s officers and directors for alleged violations of the

Lannett Company (LCI) Accused of Price-Fixing and Misleading Investors According to the complaint against the company’s officers and directors for breaches of fiduciary duty from 2013 to the present, Lannett’s

Nevro Corp. (NVRO) Accused of Scheming to Steal Trade Secrets According to the complaint against the company’s officers and directors for breaches of their fiduciary duties from January 8, 2016

Freshpet, Inc. (FRPT) Accused of Touting Promising Outlook Despite Production Problems According to the complaint against the company’s officers and directors for breaches of their fiduciary duties from March 2015

Longfin Corp. (LFIN) Accused of Making False Statements in its SEC Filings According to the complaint, Longfin inflated the trading price of Class A Shares by making materially false and

India Globalization Capital, Inc. (IGC) Accused of Misstating Its Business Prospects According to the filed class action complaint against the company’s officers and directors for alleged violations of the Securities

Cognizant Technology Solutions Corporation (CTSH) Shareholder Class Action Alleging Defendants Made Materially False and Misleading Statements to Conceal Bribery Scheme Survives Motion to Dismiss Investors filed a class action complaint